KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Oct 21, 2025 >>  ABB India 5242.45  [ 0.26% ]  ACC 1845  [ 0.74% ]  Ambuja Cements 567.75  [ 0.39% ]  Asian Paints Ltd. 2508.35  [ -0.22% ]  Axis Bank Ltd. 1235.9  [ 0.80% ]  Bajaj Auto 9109.7  [ -0.27% ]  Bank of Baroda 270.1  [ -0.48% ]  Bharti Airtel 2043.35  [ -0.39% ]  Bharat Heavy Ele 234.6  [ 0.34% ]  Bharat Petroleum 339.1  [ 0.43% ]  Britannia Ind. 6061  [ -0.14% ]  Cipla 1663.85  [ 1.50% ]  Coal India 391.05  [ 0.12% ]  Colgate Palm. 2259.4  [ 0.70% ]  Dabur India 506.2  [ 0.33% ]  DLF Ltd. 771.7  [ -0.26% ]  Dr. Reddy's Labs 1289.55  [ 0.56% ]  GAIL (India) 178.3  [ -0.06% ]  Grasim Inds. 2869  [ 0.47% ]  HCL Technologies 1487.85  [ -0.53% ]  HDFC Bank 1007.3  [ 0.40% ]  Hero MotoCorp 5630  [ -0.16% ]  Hindustan Unilever L 2592.3  [ -0.03% ]  Hindalco Indus. 785  [ -0.22% ]  ICICI Bank 1382.2  [ -0.63% ]  Indian Hotels Co 744.2  [ 0.12% ]  IndusInd Bank 758.35  [ -0.17% ]  Infosys L 1472  [ 0.72% ]  ITC Ltd. 412.85  [ -0.02% ]  Jindal Steel 1006.9  [ 0.13% ]  Kotak Mahindra Bank 2196  [ -0.82% ]  L&T 3887.1  [ 0.35% ]  Lupin Ltd. 1941.5  [ -0.17% ]  Mahi. & Mahi 3619.65  [ 0.60% ]  Maruti Suzuki India 16389.5  [ -0.26% ]  MTNL 41.84  [ 0.75% ]  Nestle India 1286.75  [ 0.14% ]  NIIT Ltd. 105.9  [ 1.53% ]  NMDC Ltd. 75.62  [ 0.48% ]  NTPC 342.1  [ 0.00% ]  ONGC 248.05  [ -0.22% ]  Punj. NationlBak 117.7  [ -0.34% ]  Power Grid Corpo 288.75  [ 0.36% ]  Reliance Inds. 1465.15  [ -0.11% ]  SBI 908.1  [ 0.14% ]  Vedanta 475.6  [ 0.35% ]  Shipping Corpn. 231.5  [ 2.39% ]  Sun Pharma. 1690.3  [ 0.10% ]  Tata Chemicals 912.6  [ 1.05% ]  Tata Consumer Produc 1174.6  [ -0.20% ]  Tata Motors Passenge 401.9  [ 0.55% ]  Tata Steel 172.8  [ 0.52% ]  Tata Power Co. 398.45  [ -0.30% ]  Tata Consultancy 3007.25  [ -0.23% ]  Tech Mahindra 1446.5  [ 0.12% ]  UltraTech Cement 12346.5  [ 0.08% ]  United Spirits 1359.55  [ -0.44% ]  Wipro 241.45  [ 0.08% ]  Zee Entertainment En 104.4  [ 0.24% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

MEDICAMEN BIOTECH LTD.

21 October 2025 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE646B01010 BSE Code / NSE Code 531146 / MEDICAMEQ Book Value (Rs.) 159.80 Face Value 10.00
Bookclosure 19/09/2025 52Week High 630 EPS 5.24 P/E 62.36
Market Cap. 443.22 Cr. 52Week Low 293 P/BV / Div Yield (%) 2.04 / 0.31 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
MBL was incorporated as a public limited company under the Companies Act, 1956, on December 22, 1993. The certificate of commencement of business was obtained on January 31, 1994. The company has jointly been promoted by Mr.V.Kumar, Mr.Bal Kishan Gupta, Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh.

MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst, Cadila, Hindustan Ciba, Purepharma, Oboi Labs etc. and exporting to countries like Germany, Russia, Holland, CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales.

MBL has obtained permission for production of tablets, capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited, New Delhi and Pure Pharma Private Limited, Indore respectively.

2010

-The Company has recommended a final dividend of Rs. 0.75 per equity share (being 7.5% on the face value of Rs. 10 per share)

-The Company appointed Mr. B.K.Gupta as Managing Director.

2011

-The Company gets ANVISA.Brazil approval for Non Beta Lactum solid Tablets and Coated tablets manufactured at its Plant situated at SP 1192,A & B, Phase 4, Bhiwadi - 301019, Rajasthan.

2013

-Ms. Harshita Sharma has been appointed as Additional Director of the company.

2016 -Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd.

2019 -FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant.

2020 -Global API Facility started Dahej API Plant.

2021 -Operations started Haridwar formulation Unit II(FDF).

2023 --Medicamen Biotech Gains On Successful Anda Filing For Bortezomib Injections.

2024 -Medicamen Biotech's Bhiwadi Manufacturing Facility Secures EU GMP Approval from Greece. -Medicamen Biotech's Sterile injectable Facility Received USFDA Approval.